Insights

Gene-editing Therapies EdiGene focuses on developing transformative genetic medicines using proprietary gene-editing technologies. This innovative approach presents opportunities for partnerships with healthcare providers and pharmaceutical companies looking to advance precision medicine solutions.

Leaper-based RNA Editing The LEAPER-based in vivo RNA base editing platform by EdiGene offers a cutting-edge therapeutic avenue. Sales professionals can explore collaborations with organizations interested in pioneering RNA-focused therapies and bioinformatics applications.

Bioinformatics & Screening With a strong emphasis on bioinformatics and high throughput genome-editing screening, EdiGene stands out in the biotechnology research sector. Sales teams can target businesses seeking advanced genome-editing technologies for drug discovery and development.

Strategic Funding Having secured significant funding of $62M, EdiGene demonstrates financial stability for growth and expansion. Sales development representatives can leverage this financial backing to attract investors and explore strategic partnerships for mutual business growth.

Competitive Landscape Among comparable companies like Editas Medicine and Beam Therapeutics, EdiGene holds its ground with a focus on gene-editing innovations. Sales professionals can capitalize on this competitive positioning to differentiate EdiGene's offerings and target niche market segments.

EdiGene Inc. Tech Stack

EdiGene Inc. uses 8 technology products and services including Baidu Analytics, Modernizr, jQuery, and more. Explore EdiGene Inc.'s tech stack below.

  • Baidu Analytics
    Analytics
  • Modernizr
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Swiper
    Javascript Libraries
  • PHP
    Programming Languages
  • HSTS
    Security
  • X-XSS-Protection
    Security
  • Animate.css
    UI Frameworks

Media & News

EdiGene Inc.'s Email Address Formats

EdiGene Inc. uses at least 1 format(s):
EdiGene Inc. Email FormatsExamplePercentage
FirstLast@edigene.comJohnDoe@edigene.com
60%
LastFirst@edigene.comDoeJohn@edigene.com
20%
FirstLas@edigene.comJohnDoe@edigene.com
13%
FiLast@edigene.comJoDoe@edigene.com
7%

Frequently Asked Questions

Where is EdiGene Inc.'s headquarters located?

Minus sign iconPlus sign icon
EdiGene Inc.'s main headquarters is located at No. 22 Kexueyuan Road Changping District Beijing, Beijing 102200 CN. The company has employees across 3 continents, including AsiaNorth AmericaEurope.

What is EdiGene Inc.'s official website and social media links?

Minus sign iconPlus sign icon
EdiGene Inc.'s official website is edigene.com and has social profiles on LinkedIn.

How much revenue does EdiGene Inc. generate?

Minus sign iconPlus sign icon
As of June 2024, EdiGene Inc.'s annual revenue reached $75M.

What is EdiGene Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
EdiGene Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does EdiGene Inc. have currently?

Minus sign iconPlus sign icon
As of June 2024, EdiGene Inc. has approximately 201 employees across 3 continents, including AsiaNorth AmericaEurope. Key team members include Vice President Corporate Strategy And Business Development: B. Z.Head Of Human Resources: R. R.Vp Of Business Development: K. F.. Explore EdiGene Inc.'s employee directory with LeadIQ.

What industry does EdiGene Inc. belong to?

Minus sign iconPlus sign icon
EdiGene Inc. operates in the Biotechnology Research industry.

What technology does EdiGene Inc. use?

Minus sign iconPlus sign icon
EdiGene Inc.'s tech stack includes Baidu AnalyticsModernizrjQuerySwiperPHPHSTSX-XSS-ProtectionAnimate.css.

What is EdiGene Inc.'s email format?

Minus sign iconPlus sign icon
EdiGene Inc.'s email format typically follows the pattern of . Find more EdiGene Inc. email formats with LeadIQ.

How much funding has EdiGene Inc. raised to date?

Minus sign iconPlus sign icon
As of June 2024, EdiGene Inc. has raised $62M in funding. The last funding round occurred on Apr 21, 2021 for $62M.

When was EdiGene Inc. founded?

Minus sign iconPlus sign icon
EdiGene Inc. was founded in 2015.
EdiGene Inc.

EdiGene Inc.

Biotechnology ResearchBeijing, China201-500 Employees

EdiGene is a clinical-stage company focused on translating gene-editing technologies into transformative genetic medicines for patients with significant unmet medical needs. Anchored by its proprietary technologies of gene editing, bioinformatics, and high throughput genome-editing screening, EdiGene advances the pipeline on therapeutic platforms of LEAPER-based in vivo RNA base editing, ex vivo gene-editing hematopoietic stem cells, and ex vivo gene-editing T cells for allogeneic CAR-T.

Section iconCompany Overview

Headquarters
No. 22 Kexueyuan Road Changping District Beijing, Beijing 102200 CN
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $62M

    EdiGene Inc. has raised a total of $62M of funding over 7 rounds. Their latest funding round was raised on Apr 21, 2021 in the amount of $62M.

  • $50M$100M

    EdiGene Inc.'s revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $62M

    EdiGene Inc. has raised a total of $62M of funding over 7 rounds. Their latest funding round was raised on Apr 21, 2021 in the amount of $62M.

  • $50M$100M

    EdiGene Inc.'s revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.